Saturday 17 October 2026
Export MODVQ’s income statement to Excel — free account
ModivCare Inc.
MODVQ Healthcare Medical Care Facilities
ModivCare Inc.’s revenue for fiscal 2024 (year ended December 2024) was $2.8 billion, up 1.32% from fiscal 2023. In the quarter to September 2025, revenue fell 3.18%, EPS fell 171.7% and free cash flow fell 3,767.7%, each against the same quarter a year earlier. Revenue growth for five consecutive years.
0.02
0.00
0.00%
Follow MODVQ
| Sep '25 | Jun '25 | Mar '25 | Dec '24 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 |
+8 more quarters Free account |
P/S ratio |
0.00 | 0.02 | 0.01 | 0.06 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
(0.05) | (2.02) | (0.23) | 5.61 | |
P/B ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
0.36 | 0.48 | 0.46 | 0.47 | |
EV/EBITDA |
10.14 | 11.22 | 9.86 | 10.23 | |
EV/Operating CF |
(7.76) | (20.07) | (12.85) | (205.40) | |
EV/FCF |
(6.59) | (14.69) | (10.34) | (38.67) | |
Quick Ratio |
1.52 | 0.75 | 0.75 | 0.75 | |
Current Ratio |
1.64 | 0.80 | 0.80 | 0.79 | |
Net Debt/EBITDA |
(4.67) | 52.61 | 50.96 | 34.93 | |
Debt/Assets |
4.40% | 98.06% | 81.18% | 76.21% | |
Debt/Equity |
(0.13) | (3.52) | (15.54) | (32.77) | |
Asset Turnover |
1.75 | 1.76 | 1.60 | 1.63 | |
Operating CF/Net income |
0.69 | 0.07 | 1.63 | (1.28) | |
Capex/Depreciation |
(0.23) | (0.02) | (0.14) | (0.19) | |
Interest Coverage |
(0.83) | (7.23) | (0.11) | 0.16 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
12.41% | 10.70% | 12.08% | 10.56% | |
Intangible Assets out of Total Assets |
0.46 | 0.47 | 0.56 | 0.58 | |
Share Based Compensation of Revenue |
0.09% | 2.22% | 0.19% | 0.27% | |
Graham Net Nets |
(473.80) | (27.81) | (65.10) | (7.10) | |
Graham Number |
150.89 | 131.56 | 47.07 | 29.33 | |
Earnings Yield |
(16,526.32%) | (903.53%) | (1,219.70%) | (119.51%) | |
Free Cash Flow Yield |
(5,371.92%) | (198.24%) | (644.45%) | (20.19%) | |
Revenue per Share |
47.20 | 45.95 | 45.41 | 49.35 | |
Operating CF per Share |
(3.51) | (1.55) | (5.73) | 2.11 | |
Capex per Share |
(0.43) | (0.46) | (0.28) | (0.38) | |
Free Cash Flow per Share |
(3.93) | (2.01) | (6.01) | 1.73 | |
Cash per Share |
8.98 | 8.40 | 8.37 | 7.94 | |
Shareholders Equity per Share |
(32.23) | (27.29) | (6.12) | (2.70) | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
(32.23) | (27.29) | (6.12) | (2.70) | |
Free Cash Flow |
(56.67) | (28.86) | (86.15) | 24.70 | |
Working Capital |
229.53 | (134.35) | (134.22) | (129.11) | |
Capital Expenditures |
(6.18) | (6.65) | (4.06) | (5.35) | |
Net Current Asset Value |
(1,296.41) | (1,245.21) | (1,231.37) | (1,197.43) | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.01 | 0.01 | 0.01 | 0.01 | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
395.35 | 398.09 | 371.95 | 365.98 | |
Average Payables |
70.42 | 69.23 | 56.15 | 69.15 | |
Average Assets |
1,535.66 | 1,541.85 | 1,720.61 | 1,710.80 | |
Average Common Equity |
(240.56) | (191.06) | 24.10 | 58.86 |
Columns are period end dates